BBIO - BridgeBio Pharma GAAP EPS of -$0.98 revenue of $1.6M August, 03 2023 10:24 AM BridgeBio Pharma Inc. 2023-08-03 10:24:48 ET BridgeBio Pharma press release ( NASDAQ: BBIO ): Q2 GAAP EPS of -$0.98. Revenue of $1.6M. For further details see: BridgeBio Pharma GAAP EPS of -$0.98, revenue of $1.6M